Liu Xiao-Bo, Gao Zi-Ye, Zhang Qing-Hui, Pandey Sandeep, Gao Bo, Yang Fan, Tong Qiang, Li Sheng-Bao
Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Front Oncol. 2020 Feb 21;10:178. doi: 10.3389/fonc.2020.00178. eCollection 2020.
Neutrophil lymphocyte ratio (NLR), Lymphocyte mononuclear cell ratio (LMR), and Platelet lymphocyte ratio (PLR) can be used as various prognostic factors for malignant tumors, but the value of prognosis for patients with adenocarcinoma of the esophagogastric junction (AEG) has not been determined. This study used meta-analysis to assess the value of these indicators in the evaluation of AEG prognosis. Relevant literatures on the prognostic relationship between NLR, LMR, PLR, and AEG was retrieved from PubMed, Web of Science, Embase, Cochrane Library, Cochrane Central Register of Controlled Trials, Wanfang data, and Chinese National Knowledge Infrastructure. The search time from database establishment to June 30, 2019. The language is limited to English and Chinese. Data was analyzed using Stata 15.0 software. Six retrospective studies were included, five of them involved NLR and six of them involved PLR. No LMR literature that adequately satisfied the conditions was retrieved. Increased NLR was significantly associated with a significant reduction in overall survival (OS), cancer-specific survival (CSS), or disease specific survival (DSS) in patients with AEG [hazard ratio (HR) = 1.545, 95% CI: 1.096-2.179, < 0.05]. Subgroup analysis showed that NLR had significant value in the prognosis of both Chinese and Non-Chinese patients ( = 0.009 vs. = 0.000). NLR had significant prognostic value for ≥3 and <3 groups ( = 0.022 vs. = 0.000). NLR has a significant prognostic value for samples ≥500 and <500 ( = 0.000 vs. = 0.022). NLR and OS/CSS/DSS single factor meta-regression showed that regional NLR cut-off values and sample size may be the source of heterogeneity in AEG patients (all < 0.05). There was no significant association between elevated PLR and OS in patients with AEG (HR = 1.117, 95% CI: 0.960-1.300, > 0.05). PLR had no significant prognostic value for both Chinese and UK patients ( = 0.282 vs. = 0.429). PLR had no significant prognostic value for ≥150 group and <150 group ( = 0.141 and = 0.724). No significant prognostic value was found in either the 300 group and <300 group ( = 0.282 vs. = 0.429). Preoperative NLR rise was an adverse prognostic indicator of AEG. High-risk patients should be treated promptly. The results showed that PLR was not recommended as a prognostic indicator of AEG.
中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)以及血小板与淋巴细胞比值(PLR)可作为恶性肿瘤的多种预后因素,但食管胃交界腺癌(AEG)患者的预后价值尚未确定。本研究采用荟萃分析来评估这些指标在AEG预后评估中的价值。从PubMed、Web of Science、Embase、Cochrane图书馆、Cochrane对照试验中心注册库、万方数据和中国知网检索有关NLR、LMR、PLR与AEG预后关系的相关文献。检索时间从数据库建立至2019年6月30日。语言限于英文和中文。使用Stata 15.0软件进行数据分析。纳入六项回顾性研究,其中五项涉及NLR,六项涉及PLR。未检索到充分满足条件的LMR文献。AEG患者中,NLR升高与总生存期(OS)、癌症特异性生存期(CSS)或疾病特异性生存期(DSS)显著降低显著相关[风险比(HR)=1.545,95%可信区间:1.096 - 2.179,P<0.05]。亚组分析显示,NLR在中国患者和非中国患者的预后中均具有显著价值(P = 0.009对P = 0.000)。NLR对≥3和<3组具有显著预后价值(P = 0.022对P = 0.000)。NLR对样本量≥500和<500具有显著预后价值(P = 0.000对P = 0.022)。NLR与OS/CSS/DSS单因素荟萃回归显示,区域NLR临界值和样本量可能是AEG患者异质性的来源(均P<0.05)。AEG患者中,PLR升高与OS无显著关联(HR = 1.117,95%可信区间:0.960 - 1.300,P>0.05)。PLR对中国患者和英国患者均无显著预后价值(P = 0.282对P = 0.429)。PLR对≥150组和<150组无显著预后价值(P = 0.141和P = 0.724)。在300组和<300组中均未发现显著预后价值(P = 0.282对P = 0.429)。术前NLR升高是AEG的不良预后指标。高危患者应及时治疗。结果表明,不建议将PLR作为AEG的预后指标。